Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gander, S.
Right arrow Articles by Finch, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gander, S.
Right arrow Articles by Finch, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 46, 61-67
© 2000 The British Society for Antimicrobial Chemotherapy

The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of Gram-positive bacteria

Sarah Gander* and Roger Finch

Division of Microbiology and Infectious Diseases, School of Clinical Laboratory Sciences, University of Nottingham, The City Hospital, Nottingham NG5 1PB, UK

Using a biofilm model, infections by Staphylococcus aureus, coagulase-negative staphylococci and enterococci were studied. The biofilms were exposed to quinupristin/dalfopristin and five comparator antibiotics: ciprofloxacin, vancomycin, teicoplanin, flucloxacillin and erythromycin. Two methods of exposure to the drugs were used: constant for 1 h, and exponentially decreasing, with the rate of dilution being matched to the half-lives of the antibiotics. The effects of antibiotic exposure were monitored by performing viable counts on the cells eluted from the biofilms. The results are presented as the inhibitory or bactericidal effect (the reduction in numbers of bacteria eluted from the biofilms) and recovery times (the time taken for the number of cells eluted from the biofilms to return to the number eluted before the drug exposure). Quinupristin/dalfopristin was the most effective of the six antibiotics studied, especially against enterococci. However, there were no significant differences in the effects, inhibitory/ bactericidal or recovery times, produced by the two methods of exposure. The two glycopeptides showed a surprising lack of activity.

* Corresponding author. Tel: +44-115-969-1169; Fax: +44-115-962-7766; E-mail: sarah.gander{at}nottingham.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
S. Gander, A. Kinnaird, and R. Finch
Telavancin: in vitro activity against staphylococci in a biofilm model
J. Antimicrob. Chemother., August 1, 2005; 56(2): 337 - 343.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. A. Wu, C. Kusuma, J. J. Mond, and J. F. Kokai-Kun
Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces
Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3407 - 3414.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Saleh-Mghir, N. Ameur, C. Muller-Serieys, F. Ismael, F. Lemaitre, L. Massias, C. Feger, R. Bleton, and A.-C. Cremieux
Combination of Quinupristin-Dalfopristin (Synercid) and Rifampin Is Highly Synergistic in Experimental Staphylococcus aureus Joint Prosthesis Infection
Antimicrob. Agents Chemother., April 1, 2002; 46(4): 1122 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. Gander, K. Hayward, and R. Finch
An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model
J. Antimicrob. Chemother., February 1, 2002; 49(2): 301 - 308.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.